Robotics & Devices

Cradle

Cradle, a pioneering platform in the field of protein engineering, utilizes advanced machine learning to transform the way proteins are designed. This innovative tool aims to streamline and accelerate the protein design process significantly, enabling researchers and scientists to develop proteins with specific properties more efficiently than traditional methods allow. By employing cutting-edge generative machine learning models, Cradle predicts optimal genetic modifications required for desired protein characteristics, thus bypassing the trial-and-error limitations of conventional approaches. At the core of Cradle’s capabilities are its generative machine learning models, which are honed on an extensive dataset comprising nearly one billion protein sequences. These models enable the platform to predict the performance of various protein variants accurately. As each experimental cycle is completed, the models learn and enhance their predictive accuracy and protein design capabilities, providing users with optimized protein variants more swiftly. Cradle is designed for a diverse range of applications across several industries. In therapeutics, it aids in designing more effective enzymes, antibodies, and vaccines. In the chemical sector, it facilitates the creation of novel enzymes suitable for sustainable chemical synthesis and biomanufacturing. Further applications include developing new proteins for bio-based materials and plastics, as well as engineering proteins to enhance food production and processing. Among Cradle’s unique selling points are its ability to optimize multiple protein properties in a single design cycle, its user-friendly interface that simplifies use for individuals without a machine learning background, and its strong emphasis on data privacy and security. These elements ensure that user data remains confidential while granting users ownership over their intellectual outputs. The platform is also integrated with Ginkgo Bioworks' Foundry, ensuring seamless communication and data exchange between systems—an accolade to its integration capabilities. Notably, Cradle has secured a seed funding round of €5.5 million, underscoring confidence from prominent investors like Index Ventures and Kindred Capital. Recognized for its leadership in AI-driven biology and protein engineering, it continuously receives attention for its contributions to the field. Recent developments include a strategic partnership with Ginkgo Bioworks, aimed at expanding the reach of its machine learning technology to additional bio research and development teams. Cradle actively engages its community through informative blog posts, offering insights into AI in protein design and best practices for data collection. Through these advancements and features, Cradle stands out as a transformative tool in bioengineering, offering a sophisticated, efficient, and secure solution for modern protein design challenges.

Clone Robotics

Clone Robotics is focused on developing musculoskeletal, intelligent androids designed to solve everyday problems for individuals and businesses 1. Their flagship product, Clone, is a bipedal android companion that utilizes Myofiber, a revolutionary artificial muscle technology 14. Key Features and Capabilities: Clone features a soft-bodied effector, biomorphic design, and operates using water and electricity 4. Myofiber enables natural, human-like movement with a combination of weight, power density, speed, force-to-weight ratio, and energy efficiency 4. The robot also incorporates natural language interfaces 4. Potential Use Cases and Applications: Clone's versatility makes it suitable for research, education, and industrial automation 3, with potential applications ranging from personal assistance to commercial tasks 1. Unique Selling Points and Advantages: The Myofiber artificial muscle technology sets Clone Robotics apart, offering efficient and natural movement 14. The ability to operate using water and electricity is another key advantage 4. Technical Specifications and Requirements: Clone features a musculoskeletal system based on a natural human skeleton, along with a complex nervous and vascular system 4. The robot is designed to be lightweight and durable 4. Achievements, Awards, and Recognition: Myofiber technology was pioneered in 2021, marking a significant technological achievement 4. Recent Updates and Developments: Clone Robotics has made advancements in teleoperated robotic hands 1, and is producing robots with Westworld-like capabilities 15. They offer a lifelike robotic hand for approximately $2,800 and are developing Neoclone, a next-generation android 1.

Genesis Therapeutics

Genesis Therapeutics is a biotech leader in molecular AI that unites deep learning and physics-based machine learning in its proprietary GEMS platform and Pearl foundation model to unlock tough protein targets and rapidly discover highly potent, selective small-molecule therapeutics across multiple disease areas. With state-of-the-art protein–ligand prediction, industry-leading speed, and a growing pipeline, Genesis partners with pharma while advancing its own AI-enabled medicines.